🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the makers of Tylenol, claiming the corporations hid alleged dangers that the drug posed to pediatric neurological development.

This legal action comes thirty days after Donald Trump promoted an unverified association between taking acetaminophen - referred to as acetaminophen - during pregnancy and autism spectrum disorder in offspring.

Paxton is taking legal action against the pharmaceutical giant, which previously sold the drug, the exclusive pain medication suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a statement, he stated they "betrayed America by profiting off of discomfort and pushing pills ignoring the potential hazards."

Kenvue states there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These companies misled for generations, deliberately risking numerous people to boost earnings," Paxton, a Republican, said.

The manufacturer said in a statement that it was "deeply concerned by the spread of false claims on the safety of acetaminophen and the potential impact that could have on the well-being of women and children in America."

On its online platform, Kenvue also stated it had "consistently assessed the applicable studies and there is no credible data that demonstrates a verified association between consuming paracetamol and autism."

Organizations acting on behalf of medical professionals and healthcare providers agree.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in acetaminophen - is one of the few options for women during pregnancy to treat discomfort and elevated temperature, which can pose significant medical dangers if ignored.

"In more than two decades of research on the utilization of acetaminophen in pregnancy, no reliable research has conclusively proven that the consumption of paracetamol in any stage of pregnancy results in neurological conditions in young ones," the group commented.

This legal action mentions latest statements from the former administration in claiming the medication is potentially dangerous.

Last month, the former president caused concern from health experts when he told women during pregnancy to "resist strongly" not to consume acetaminophen when ill.

The US Food and Drug Administration then issued a notice that physicians should think about restricting the usage of acetaminophen, while also stating that "a causal relationship" between the medication and autism in young ones has not been established.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had vowed in April to undertake "extensive scientific investigation" that would establish the cause of autism in a short period.

But experts cautioned that discovering a single cause of autism spectrum disorder - thought by researchers to be the consequence of a intricate combination of genetic and environmental factors - would be difficult.

Autism is a form of permanent neurological difference and disability that impacts how persons encounter and relate to the surroundings, and is identified using medical professional evaluations.

In his court filing, the attorney general - a Trump ally who is campaigning for US Senate - alleges the manufacturer and J&J "deliberately disregarded and attempted to silence the research" around paracetamol and autism.

The lawsuit attempts to require the corporations "remove any promotional materials" that asserts acetaminophen is secure for expectant mothers.

The court case mirrors the concerns of a group of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in recently.

The court dismissed the legal action, declaring studies from the parents' expert witnesses was inconclusive.